Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

View All Documentation

856707C

Avanti

17:1 Lyso PE

1-(10Z-heptadecenoyl)-sn-glycero-3-phosphoethanolamine, chloroform

Sinonimo/i:

1-heptadecenoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; PE(17:1(10Z)/0:0); 110699

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C22H44NO7P
Numero CAS:
1246298-09-8
Peso molecolare:
465.56
Codice UNSPSC:
12352211
NACRES:
NA.25

Saggio

>99% (LPE; may contain up to 10% of the 2-LPE isomer, TLC)

Forma fisica

liquid

Confezionamento

pkg of 1 × 1 mL (856707C-5mg)

Produttore/marchio commerciale

Avanti Research™ - A Croda Brand 856707C

Concentrazione

5 mg/mL (856707C-5mg)

Tipo di lipide

cardiolipins
phospholipids

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Stringa SMILE

O[C@](COP([O-])(OCC[NH3+])=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O

Confezionamento

5 mL Clear Glass Sealed Ampule (856707C-5mg)

Note legali

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Comunemente ordinati con questo prodotto

N° Catalogo
Descrizione
Determinazione del prezzo

SMB00506

1-Heptadecanoyl-rac-glycerol, ≥98% (HPLC)

830756P

17:0 PE, Avanti Research™ - A Croda Brand

850103P

17:1 Lyso PI, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt), powder

855676P

17:0 Lyso PC, Avanti Research™ - A Croda Brand

858127C

17:1 Lyso PG, 1-(10Z-heptadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

858141C

17:1 Lyso PS, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), chloroform

858141P

17:1 Lyso PS, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), powder

860517P

C17 Ceramide (d18:1/17:0), Avanti Research™ - A Croda Brand

860585P

17:0 SM (d18:1/17:0), Avanti Research™ - A Croda Brand 860585P, powder

860640P

Sphingosine (d17:1), Avanti Research™ - A Croda Brand 860640P, powder

860903P

17:0-17:1-17:0 D5 TG, Avanti Research™ - A Croda Brand 860903P, powder

LM1000

12:0-13:0 PC, Avanti Research™ - A Croda Brand LM1000, methanol solution

LM4100

cholesterol (D7), Avanti Research™ - A Croda Brand LM4100, methanol solution

Pittogrammi

Skull and crossbonesHealth hazard
GHS06,GHS08

Avvertenze

Danger

Classi di pericolo

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

Organi bersaglio

Central nervous system, Liver,Kidney

Classe di pericolosità dell'acqua (WGK)

WGK 3

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Peng Wu et al.
Chinese medicine, 15, 9-9 (2020-01-31)
Our previous clinical evidence suggested that the direct application of "Sanse powder" the main ingredient of "Yiceng" might represent an alternative treatment for knee osteoarthritis. However, the mechanism underlying its effect is poorly understood. In this study, we investigated the
Tsukasa Yagi et al.
Cancers, 12(1) (2020-01-01)
Ovarian cancer remains a highly lethal disease due to its late clinical presentation and lack of reliable early biomarkers. Protein-based diagnostic markers have presented limitations in identifying ovarian cancer. We tested the potential of phospholipids as markers of ovarian cancer
Biyu Hou et al.
Life sciences, 245, 117352-117352 (2020-02-02)
The depot-specific differences in lipidome of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) reflect heterogeneity of white adipose tissue (WAT), which plays a central role in its distinct response to outside stimuli. However, the detailed lipidome of depot-specific
Jordon M Inloes et al.
Biochemistry, 57(39), 5759-5767 (2018-09-18)
Deleterious mutations in the serine hydrolase DDHD domain containing 1 (DDHD1) cause the SPG28 subtype of the neurological disease hereditary spastic paraplegia (HSP), which is characterized by axonal neuropathy and gait impairments. DDHD1 has been shown to display PLA1-type phospholipase

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.